Open Access Open Access  Restricted Access Subscription Access

Takayasu Arteritis: Current Perspective and Brief Narrative Review


Affiliations
1 Undergraduate Student, India
2 Professor and Head, Department of Cardiology, India
3 Professor and Head, Department of Interventional Radiology (Radiodiagnosis), Bharati Vidyapeeth (Deemed to be University) Medical College, Hospital and Research Centre, Pune, Maharashtra, India., India
 

   Subscribe/Renew Journal


Takayasu Arteritis (TA) is a rare chronic inflammatory vascular disorder that mainly causes stenosis and occlusion of large vessels of the body. TA is prevalent in the Asian population with a higher evidence seen in young females. Even though TA has an unclear etiopathogenesis, there are numerous genetic links found associated with TA. Various interventional and radiological investigations prove to be the key for confirming the diagnosis of TA, following which appropriate medical and surgical line of treatment are done, however there is no universal protocol for managing TA. TA has a tendency to progress to serious life threatening complications, hence early diagnosis and treatment should be the goal, also aimed at preventing future re-stenosis, a well-studied complication of TA. It is also crucial to diagnose TA from other overlapping diseases, owing to its peculiar clinical presentation and characteristic radiological findings, which is often confused with other vascular disorders. TA as a disease greatly impacts the quality of life in affected patients with a worse prognosis seen in those who are predisposed to certain well documented risk factors. Furthermore, an increasing number of cases reporting an interesting link between arteritis and the COVID-19 virus have been reported in recent times, which might prove to be crucial in the forthcoming years for establishing this association. Our article aims to sensitize clinicians with regard to an increased awareness of TA in various clinical settings for better patient management and improved prognosis.


Keywords

COVID-19, diagnosis, endovascular, giant cell arteritis, interventions, takayasu arteritis, treatment
Subscription Login to verify subscription
User
Notifications
Font Size



  • Takayasu Arteritis: Current Perspective and Brief Narrative Review

Abstract Views: 308  |  PDF Views: 159

Authors

Amanpreet Singh Wasir
Undergraduate Student, India
Ravi Kalra
Professor and Head, Department of Cardiology, India
John D Souza
Professor and Head, Department of Interventional Radiology (Radiodiagnosis), Bharati Vidyapeeth (Deemed to be University) Medical College, Hospital and Research Centre, Pune, Maharashtra, India., India

Abstract


Takayasu Arteritis (TA) is a rare chronic inflammatory vascular disorder that mainly causes stenosis and occlusion of large vessels of the body. TA is prevalent in the Asian population with a higher evidence seen in young females. Even though TA has an unclear etiopathogenesis, there are numerous genetic links found associated with TA. Various interventional and radiological investigations prove to be the key for confirming the diagnosis of TA, following which appropriate medical and surgical line of treatment are done, however there is no universal protocol for managing TA. TA has a tendency to progress to serious life threatening complications, hence early diagnosis and treatment should be the goal, also aimed at preventing future re-stenosis, a well-studied complication of TA. It is also crucial to diagnose TA from other overlapping diseases, owing to its peculiar clinical presentation and characteristic radiological findings, which is often confused with other vascular disorders. TA as a disease greatly impacts the quality of life in affected patients with a worse prognosis seen in those who are predisposed to certain well documented risk factors. Furthermore, an increasing number of cases reporting an interesting link between arteritis and the COVID-19 virus have been reported in recent times, which might prove to be crucial in the forthcoming years for establishing this association. Our article aims to sensitize clinicians with regard to an increased awareness of TA in various clinical settings for better patient management and improved prognosis.


Keywords


COVID-19, diagnosis, endovascular, giant cell arteritis, interventions, takayasu arteritis, treatment

References